If patients with renal diseases had to undergo surgical intervention, they should be prepared in such a way to be in a stable phase of the underlying surgical disease, without any infection, euvolemic, with satisfactory blood pressure and corrected electrolyte balance. These patients need to be hydrated well before intervention, the fall of blood pressure during intervention should be avoided and adequate hydration after the intervention must be continued (taking into account the condition of the kidneys, heart and age of patient). It is assumed that nephrotoxic drugs are to be evaded in renal patients or, if they were necessary, the dosage and dosing interval should be adjusted and prolonged, respectively. The use of radiographic contrast is not advisable, but if required, plentiful hydration will be needed, the least workable contrast dose and, if possible, with lower ionic charge and lower osmolarity will be administered. If surgical intervention was urgent and if there was not enough time for conservative therapy, i.e. correction of electrolytes, volemia, blood pressure and higher values of nitrate substances, a renal patient would be temporarily dialyzed in the immediate preoperative and postoperative course. Any surgical intervention in these patients may aggravate the renal function and bring the patient closer to dialysis treatment. Nevertheless, sometimes the benefit of surgical treatment for the acute surgical disease is higher (especially if it was life-threatening) than the risk of renal function exacerbation and coming closer to dialysis.
INTRODUCTION

K
idney is an excretory organ, which excretes the waste products of metabolism, water and electrolyte surplus as well as foreign substances, accordingly securing the maintenance of homeostasis. Other than excretory function, the kidneys have very significant metabolic and endocrine functions. Such complex and versatile renal function makes condition for development of multiple disorders within renal failure that are manifested by different symptoms and signs. In the initial phases of many renal diseases, symptomatology is very scarce while the physical findings are often normal. Diagnosis is made only after patient's history was obtained and objective examination and specific biochemical, X-ray, radioisotopic and other tests were performed 1 .
RENAL FUNCTION TESTS
For evaluation of renal function status, it is necessary to determine the glomerular filtration rate (GFR) and examine the tubular function of kidneys. Many of these renal functions are evaluated on the basis of clearance of certain substances. In clinical practice, endogenous creatinine clearance (Ccr) is used for glomerular filtration evaluation whose normal values are 100-150 ml/min and 85-125 ml/min for males and females, respectively 1, 2 . GFR may be exactly measured by isotopically labeled exogenous markers. Most commonly used are 51 Crethylendiamintetraacetic acid ( Yb, respectively 3 . The ratio of serum creatinine concentration and GFR is characterized by hyperbolic function, meaning that only when GFR is reduced by over 50%, the small changes of GFR correspond to significant changes of creatinine concentrations, and at that time the GFR may be evaluated on the basis of changes of serum creatinine concentrations. If : Creatinine clearance = (140 -age) x BW (kg) / 0.81 x s-creatinine (µmol/L). The obtained value of Ccr is reduced by 15% for females.
For investigation of tubular function, a series of tests is being used which evaluate the function of particular segments of tubular apparatus. In practice, the function of proximal tubules is estimated by analyzing the resorption of glucose, amino acids, phosphates and urates. In addition, fraction excretion of Na (FENa) is determined, which designates the sodium clearance expressed as GFR percentage. Lithium clearance is used for determination which part of sodium is reabsorbed from proximal tubules and which part passes to distal tubules. Lower function of proximal tubules causes the increased excretion of ß2-microglobulins. Measurement of the urine enzymes has the same diagnostic value as determination of other small proteins or peptides 5, 6 . An ability of kidneys to excrete the hydrogen ion may be determined by measurement of pH or titration acidity of the urine or ammonium ion excretion, and in some cases by measurement of the urine bicarbonates.
Renal concentration capacity is estimated by specific urine density measurement, i.e., the osmotic concentration of morning urine. Renal concentrating capacity may be determined more precisely by thirst test or upon the subcutaneous injection of 5 IU vasopressin.
KIDNEY VISUALIZATION METHODS
Sonography is applied as the first method of choice for kidney visualization because of its simple performance (no special preparation of patient or contrast medium injection is required). It presents position, size and shape of the kidneys, and the appearance and thickness of parenchyma.
Radiological methods of kidney examination includes intravenous urography with the earlier plain abdominal radiography, retrograde urography, retrograde cystography and miction cystography as well as renal blood vessel angiography. Computerized tomography (CT) provides the image of much higher resolution than the conventional radiographs. The kidneys, urinary tract and retroperitoneum may be well visualized by this method, especially when contrast medium is used.
Nuclear magnetic resonance imaging (NMRI) is a diagnostic method characterized by excellent resolution of the soft tissue image, ability of direct multiplanar image and the absence of side effects. Contrast media for magnetic resonance may be used even in patients allergic to iodine radiographic contrasts 7 . Nuclear medicine methods for examination of kidney visualization and function involve the use of radiopharmaceuticals in renal function tests as well as for the anatomy of kidneys and urinary ducts. It includes radiorenography, and static and dynamic scintigraphy 1, 3 .
ACUTE RENAL FAILURE
The acute renal failure (ARF) is a clinical syndrome of functional, biochemical and morphological disorders characterized by sudden fall of GFR, progressive azotemia, impaired water and electrolyte regulation ((hyperhydration, metabolic acidosis, hyperkalemia) and other disorders of the extracellular fluid content. Urine excretion is generally reduced in view of oliguria or anuria (less than 500ml/day and 100ml/day, respectively), although diuresis may be normal or even increased 8 . ARF is developed in 5%-7% of all hospitalized patients. It is associated with systemic diseases, acute clinical conditions, drug usage and interventional therapy. In the ICUs, the ARF incidence is 1%-25%, rising up to 50% 9, 10 The mortality rate of ARF patients is still high -20%-90% 8 . The most threatened populations are older patients, diabetics and patients with already impaired renal function 11 . Etiologically, ARF may be divided into prerenal or circulatory, renal or parenchymal and postrenal or obstructive, what is defined by location whereat different disorders interfere with mechanisms of the urine production and excretion (Table 1) .
Prerenal and postrenal ARF are potentially reversible, but if they were prolonged they might result in renal ARF with damage of renal parenchyma and chronic renal failure 8, 12 .
The clinical course of ARF is versatile and largely dependable upon etiology. Prerenal ARF is characterized by shock condition and clinical picture of basic etiopathogenetic factor, while postrenal ARF is dominated by groin pains, anuria and hematuria. Renal ARF proceeds in three phases. The initial phase encompasses the period of the initial effect of causative agent and manifested ARF, lasting from a few hours to several days. It is usually asymptomatic. Maintenance phase is characterized by oliguria or anuria with azotemia and impaired electrolyte content. There are disorders of various systems. Cardiovascular system disorders may be manifested by hypervolemia, hypertension supraventricular arrhythmias, congestive heart failure, pulmonary edema, and pericarditis. Neurological complications are presented by confusion, somnolency, disorientation, asterixis, cramps and sometimes coma. Gastrointestinal disorders involve anorexia, nausea, vomiting, ileus, as well as gastrointestinal hemorrhage due to impaired coagulation. Hematological complications include normocytic, normochromic anemia resulting from hemodilution, digestive bleeding, impaired erythropoiesis, shortened lifespan of erythrocytes or infection. ARF is often accompanied by infections, most commonly the surgical wounds, and respiratory, digestive and urinary tract 8, 11 . Metabolic acidosis is manifested by ammonia breath odor and Kussmaul breathing. And finally, there is a recovery phase consisting of two phases: early and late diuresis phase. Early diuresis phase is characterized by the onset of diuresis and urination of 1-3l/24h, reaching the volume of 10l/24h in the late diuresis phase. 
Renovascular obstruction
Obstruction of renal artery/vein
III Posternal (obstruction) ARF
Obstruction of the urine flow:
Upper urinary tract (pelvis, ureters)
Lower urinary tract (urinary bladder, urethra)
Br. 2 Preoperative preparation of patients with renal diseases
Diagnosis of ARF is based on the clinical picture, laboratory test results (Table 2) , radiological, ultrasonographic and other imaging methods as well as kidney biopsy, if required 13, 14 . Treatment of ARF is initiated after elimination of all causes, particularly prerenal and postrenal, with the intention of preventing the development of renal ARF and further damage of kidneys. It is necessary to control and maintain adequate water-electrolyte balance as well as acid-basic ratio. Appropriate blood pressure and diuresis should be maintained with evasion of both hyper-and hypovolemia and overuse of diuretics. Treatment of infection is a must with the caution not to administer nephrotoxic drugs or to correct dosage or extend the time of antibiotic administration. In addition, it is necessary to correct anemia. If required, dialysis treatment is applied in case of severe ARF with complications.
Drug dosage in patients with renal impairment. Renal impairment is followed by modification of pharmacokinetics and pharmacodynamics of many medicaments, especially those excreting via kidneys. These patients require measurement of creatinine clearance and, accordingly, reduction of dosage or extension of dosing interval according to specific guidelines. These apply to all drugs but particularly to nephrotoxic antibiotics (Table 3 ) and analgetics 11, 16 .
CHRONIC RENAL FAILURE
Chronic renal failure (CRF) is a condition of the irreversible damage of renal tissue, caused by different diseases, which gradually but in progressive manner, lead to impairment of all renal functions: excretory, metabolic, endocrine and hematological. It proceeds in four stages 17 . The causes of CRF may be glomerular conditions, tubulointerstitial nephropathy, hereditary disorders, renal urinary tract abnormalities, obstructive renal diseases, diabetic nephropathy, amyloidosis and neoplasms.
Gradual reduction of renal functions gives rise to a series of disorders: metabolism of water, electrolytes and acid-basic balance, retaining of toxic metabolites, hypertension and cardiovascular and endocrine disorders, respectively.
In CRF, the first manifestation is diminishing of renal concentrating capacity, already seen in hypofunction phase, followed subsequently by loss of renal dilution capacity and therefore, these patients may easily develop the water deficit or intoxication. Diseased kidney is not capable of regulating the sodium turnover and potassium excretion as the healthy one. With the initial GFR reduction, the phosphate absorption remains normal, producing the higher serum phosphate concentrations, what causes lower calcium in plasma and stimulation of parathyroid hormone release. Diminished synthesis of 1,25(OH)2D3 in kidneys also brings about the hypocalcemia and the resulting rise of parathyroid hormone level, as well as development of secondary hyperparathyroidism and renal osteodystrophy. Deficit of the renal mass causes the impaired excretion of acids and hydrogen ions, and consequently, 10%-20% reduction of normal GFR values results in metabolic acidosis 18 . The most reported toxic manifestations of CRF are neurological, hematological, gastrointestinal and cardiopulmonary disorders, and worth mentioning are skin changes. CRF-related endocrine disorders involve secondary hyperparathyroidism, impaired activity of the renin-angiotensin-aldosterone system, lower production of erythropoetin and gonadal dysfunction. 18 One of the most important CRF characteristics is its progression which is evident many years after the onset of the underlying disease, and continues even after the disappearance of this causative disease. The CRF progression rate depends on many factors which have been the subject Legend: U-urine, P-plasma, Na-natrium, FENa-fraction excertion of natrium, ATN-acute tubular necrosis of numerous experimental and clinical studies. Frohling and assoc. 19 report many causes of CRF progression out of which, other than the underlying renal disease, systemic hypertension and a series of intrarenal factors -either hemodynamic or metabolic -have been described. In addition, proteinuria, anemia, uncontrolled glucemia, infections as well as nutrition are known factors, too. 19, 20 The analysis of factors affecting the CRF progression allows us to apply different methods for deceleration of its progression and deferral of its terminal phase when extrarenal depuration or kidney transplantation is necessary mode of treatment. These methods would be the following: control and regulation of blood pressure, treatment of infections, maintenance of normal electrolyte values, prevention of secondary hyperparathyroidism as well as dietary regime with limited intake of salt, albumins, phosphates, and potassium 21 , and management of anemia. Besides these methods, there are pharmacological methods for deceleration of CRF progression, as follows: application of antihypertensives (ACE inhibitors, angiotensin II receptor antagonists and calcium antagonists, alpha-beta blockers [22] [23] [24] ), anticoagulation (heparin, thromboxane synthetase inhibitors) and antiaggregation therapy (aspirin, dipyridamole), serum lipid-reducing drugs, and also phosphate binders (calcium-carbonate, calcium-acetate or non-calcium phosphate binders), precipitation inhibitors (3-phosphocitrate) or calcium-phosphate crystallization (diphosphonate) as well as parathyroid hormone secretion inhibitors.
RENAL GLOMERULAR DISEASES
Renal glomerular diseases are a heterogenous group of diseases where glomeruli are solely or mostly damaged 26 . They may be primary and secondary, acute and chronic ones.
Primary glomerular diseases are conditions where changes occur mostly in glomeruli. The changes of other renal structures as well as extrarenal disorders associated with glomerular diseases are only the consequence of morphological and functional impairment of glomeruli 27 . Secondary glomerular diseases occur during various systemic, hereditary, metabolic or biochemical diseases.
The acute glomerulonephritis is a clinical syndrome characterized by sudden onset of hematuria, proteinuria, oliguria, edemas and hypertension along with GFR decrease. It is usually the result of different infections, most frequently streptococcal infections of the upper respiratory pathways and skin, although many other glomerular diseases may be manifested by clinical picture of the acute glomerulonephritis. For this reason, the acute glomerulonephritides may be divided by causes to postinfective and non-infective ones 26 .
NEPHROTIC SYNDROME
Nephrotic syndrome (NS) is a condition characterized by excessive proteinuria (over 3.5 g/24h), hypoproteinemia with hypoalbuminemia, hyperlipidemia and edemas. NS may be developed in various immune, toxic, metabolic and vascular disorders, where the primary impairment is reflected as higher permeability of glomerular capillary walls. According to causing disease, NS is divided to primary NS, occurring in primary glomerular conditions, and secondary NS developing during a series of other diseases such as systemic, hereditary and metabolic diseases, malignant conditions, infections as well as the sequela of some chemical and drug usage.
The clinical picture includes the symptoms and signs of the underlying disease and NS. Pathognomonic NS signs are pale, pasty edemas that may be so bulky that they give a picture of anasarca with effusions to body cavities. The presentation of other signs of renal diseases (hypertension or hypotension, hematuria and azothermia) and the extent of their manifestation depend upon the nature of glomerular damage. Moreover, NS may be followed by many complications. Renal patients tend to have infections both due to deficit of proteins involved in immune reaction, and malnutrition and immunosuppressive action of some lipoproteins. Long-term hyperlipidemia accelerates the 11, 12, 26 . Excessive proteinuria may cause tubular disorders, and with inadequate nutrition it may lead to malnutrition. Endocrine and metabolic disorders are not rare in NS patients. Due to hypoproteinemia, plasma vitamin and hormone levels are being reduced. This hypoproteinemia makes drug binding to plasma albumins lower, and therefore, the concentration of drug not bound to plasma proteins grows, what may give the false picture of therapeutical drug concentration. During NS, ARF may develop as a result of diminished plasma volume, but also aggressive diuretic therapy, interstitial nephritis and bilateral thrombosis of the renal veins.
Treatment of NS depends upon the underlying disease. However, only in a few cases, the elimination of causes may lead to subsidence of NS signs and symptoms (pregnancy, allergy, medicaments). In other cases, drugs that will have effect on pathogenetic mechanisms responsible for glomerular damage are used (i.e., immunosuppressive drugs for immune mechanism-related glomerular diseases). All patients are advised to rest and comply with appropriate hygienic-dietary regime (normal intake of albumins and reduced salt) with symptomatic therapy and adequate treatment of complications. Symptomatic therapy includes diuretics (with caution) and antihypertensives (ACE inhibitors and ARB are recommended), albumins if required, as well as anticoagulant and antiaggregation therapy and hypolipemics 26, 28 .
TUBULOINTERSTITIAL DISEASES
Tubulointerstitial (TIN) diseases are a versatile group of renal diseases characterized by inflammatory and scarring changes confined mostly to tubules and interstitium with scantily damaged glomerules and blood vessels of the kidneys. TIN diseases are most commonly caused by toxins, infectious agents and medicaments, and significant role is ascribed to immune mechanisms. Mononuclear infiltrates appearing in the interstitium as sequelae of TIN damage lead to release of different mediators, which alter the conditions in TIN space and bring about the renal function impairment 29 . TIN diseases are divided into the acute and chronic conditions. Acute TIN is an acute inflammatory disease affecting the renal tubules and interstitium and featured by functional tubular disorders, abnormalities of the urine sediment and ARF. Its clinical picture is varied, from asymptomatic increase of the serum urea and creatinine level or pathological urine sediment without any evidence on ARF, to developed hypertensive reaction with fever, rash, eosinophilia and oliguric ARF. Drug-related TIN is characterized by sudden loss of renal function or development of hyperkalemic, hyperchloremic metabolic acidosis, Fanconi syndrome or pathological urine sediment after administration of some drugs. NSAID-related TIN is associated with nephrotic syndrome. ARF may occur in several days or weeks following the drug application; it lasts few weeks or months and is mostly reversible.
In laboratory test results, elevated serum creatinine concentration is a major sign of the acute TIN. The impaired function of distal tubules is manifested by hyperkalemia, hyperchloremia and metabolic acidosis. Due to diminished renal concentrating capacity, hypernatremia may be present. If proximal tubules were damaged, metabolic acidosis, hypophosphatemia, hypouricemia with glycosuria, aminoaciduria and bicarbonaturia with normal kalemia would develop. Leukocytosis and eosinophilia are often (10%-30%). Anemia is mostly associated with the ARF. Hemolytic anemia may be present in TIN after the use of some drugs (penicillin, rifampin, allopurinol). These patients may have higher serum IgE concentration as well as antibodies against the given drug, drug-hapten complex or basic membrane. The urine of TIN patients shows mild proteinuria and hematuria (75%), macroscopic hematuria (44%), leukocyturia with leukocytic cylinders (scarcely), and eosinophiluria 30, 31 . Chronic TIN may appear in all progressive renal diseases such as glomerular, vascular, cystic or interstitial, and tubulointerstitium shows chronic histological changes characterized by mononuclear cellular infiltrate in the interstitium, atrophy and tubular dilatation and interstitial fibrosis. If these pathological changes were developed in the absence of glomerular or other diseases and were not associated with some of predisposing factors, it would be possible to make diagnosis of primary tubulointerstitial disease 32 . Chronic TIN is an etiologically versatile group of diseases caused by exogenous and endogenous toxins, and may also occur within paraneoplastic syndrome and immunological diseases as well as vascular and obstructive lesions of the kidneys.
In chronic TIN, CRF progression is slow, and the clinical picture is dominated by mild systemic hypertension, while edemas are rare. Anemia appears early and is not in correlation with CRF degree 30 . Nycturia, polyuria, isosthenuria, glucosuria without hyperglycemia, and proteinuria (up to 2g/day) are documented. Electrolytic imbalance depends upon localization of tubular damage and development of specific tubular disorders 32 .
PREOPERATIVE PREPARATION OF PATIENTS WITH THE RENAL DISEASES
Upon obtaining the history and examination of patients, which enable the insight into the patients' condition, i.e. whether it is severe, mid-severe or minor and the type of renal condition, it is necessary to analyze biochemical tests, urinalysis and renal functions (measurement of creatinine clearance and 24h-proteinuria). If glomerulonephritis and acute TIN were in question, immunological analyses would be also required so as to learn about the activity of disease. If nephrolithiasis or patients with recurring urinary infections were in question, it would be necessary to perform urine culture. After biochemical analyses, it would be advisable to perform renal ultrasonogra-phy for supplementing the diagnosis and information on the activity of diseases, and if required, some other radioisotopic or radiological methods would be applied 1, 2, 7 .
In ARF patients, all elective operations should be deferred until the normalization of nitrate substances. These patients need to be stabilized in such a way that their electrolytes and hypervolemia are corrected. If urgent surgical intervention was in question, it would be rational to dialyze such patient so that he/she could endure the intervention 15 . All renal diseases, particularly chronic ones, go through the phases of remission and exacerbation. If it was the phase of exacerbation, the scheduled operations would be postponed and renal disease would be treated, so it could enter silent phase that would allow for surgical treatment with the least possible risk of aggravation of the underlying disease or development of complications. The patients with glomerulonephritis should be brought into the phase of remission, the immunosuppressive therapy reduced as much as possible and he/she would be covered with antibiotics. The patients with infections should be treated for their condition and brought into the stable condition.
In case of planned surgery, CRF patients have to be in stable phase without respective complications, euvolemic, with controlled blood pressure, and no electrolytic imbalance. Electrolyte correction implies correction of phosphate, calcium, and especially potassium and bicarbonate concentrations. It is achieved by dietary regime, use of phosphate binders, vitamin D and calcium. In case of hyperkalemia, it is necessary to reduce the intake of food potassium, cut down potassium-retaining drugs and apply non-potassium sparing diuretics, and add phosphate binders. In the event of the extreme hyperkalemia and urgent surgical intervention, hypertonic glucose with the insulin and bicarbonates are applied. It is possible to correct acidosis by oral bicarbonate or soda, and in emergent and severe cases bicarbonate infusions are recommended [21] [22] [23] [24] [25] . If urgent surgery was needed, and volemia, electrolytes (especially hyperkalemia) and acidosis could not be corrected by conservative therapy, and a patient had some degree of renal failure with the azotemia, temporary dialysis would be an option.
All patients with the renal diseases should not be administered nephrotoxic medicaments before, during and after surgical interventions, and if it was indispensable, either the dosage would be reduced or dosing interval would be extended according to protocols, in relation to the extent of the renal functions. 16 (Tables 2 and 3 ). If patients with kidney conditions required contrast imaging for diagnostic purpose, it would be principally necessary to define the patients at risk. It would be the patients with serum creatinine concentrations over 0.133 mmol/L, diabetics, hypertensive patients, people over 60 years of age, dehydrated patients, one-kidney and multiple-myoma cases.
Thereupon, it would be vital to correct electrolyte imbalance, apply the minimal contrast dosage or contrasts with lower ionic-charge and osmolarity, hydrate the patient sufficiently (if they urinate well), before and after the contrast injection and probably add some of renal protection drugs (dopamine, calcium-channel blockers, theophylline).
CONCLUSION
If renal patients are to be prepared for surgical treatment, it will be necessary to be in a stable phase of the underlying renal disease, without any infection, euvolemic, with satisfactory blood pressure and corrected electrolyte balance. These patients need to be well hydrated before intervention, and the fall of blood pressure should be avoided for preservation of renal function and complications (ARF, exacerbation of renal disease). If possible, it is necessary to continue with adequate hydration (considering the status of kidneys, heart and patient's age) and avoid nephrotoxic drugs and radiographic contrast.
SUMMARY
PREOPERATIVNA PRPREMA BOLESNIKA SA BUBRE@NIM BOLESTIMA Ukoliko se bolesnici koji imaju bubre'no oboljenje podvrgavaju hirurškoj intervenciji potrebno je ih je tako pripremiti da budu u stabilnoj fazi osnovnog bubre'nog oboljenja, bez infekcije, euvolemi~ni, zadovoljavaju}e tenzije, sa korigovanim elektrolitima. Ove bolesnike je potrebno dobro hidrirati pre intervencije, izbegavati pad pritiska za vreme intervencije i nastaviti sa adekvatnom hidracijom posle intervencije (uzimaju}i u obzir stanje bubrega, ali i srca i starost bolesnika). Naravno, kod bubre'nih bolesnika je neophodno izbegavati nefrotoksi~ne lekove ili, ukoliko ih je neophodno davati, prlagoditi dozu ili produ-'iti dozni interval. Upotreba radiografskih kontrasta nije preporu~ljiva kod ovih bolesnika, ali ukoliko je to neophodno, potrebno je dobro hidrirati bolesnika, dati što manju dozu kontrasta i po mogu}stvu dati kontrast sa manjim jonskim nabojem i manjom osmolarnoš}u.
Ako je hirurška intervencija hitna i ako nema vremena za primenu konzervativne terapije u smislu korekcije elektrolita, volemije, krvnog pritiska i povišenih vrednosti azotnih materija, bubre'nog bolesnika je potrebno privremeno dijalizirati u neposrednom preoperativnom i postoperativnom toku.
Svaka hirurška intervencija kod ovih bolesnika mo'e pogoršati stanje bubre'ne funkcije i pribli'iti bolesnika leenju dijalizama. No, nekada je benefit od operativnog leenja akutnog hirurškog oboljenja ve}i (naro~ito ako je ono vitalno-ugro'avaju}e) nego rizik od pogoršavanja bubre'ne funkcije i stizanja do dijalize. Klju~ne re~i: bubre'ni bolesnici, hirurške intervencije, preoperativna priprema
